The benefit of individualized vancomycin dosing via pharmacokinetic tools: a systematic review and meta-analysis
N He, S Su, Y Yan, W Liu… - Annals of …, 2020 - journals.sagepub.com
Background: Various pharmacokinetic (PK) equations and software have been developed to
individualize vancomycin dosing. However, the benefit of using any PK information to guide …
individualize vancomycin dosing. However, the benefit of using any PK information to guide …
Dose optimization and target attainment of vancomycin in children
Vancomycin is a glycopeptide antibiotic that has been adopted in clinical practice to treat
gram-positive infections for more than 70 years. Despite vancomycin's long history of …
gram-positive infections for more than 70 years. Despite vancomycin's long history of …
Individualized vancomycin dosing with therapeutic drug monitoring and pharmacokinetic consultation service: a large-scale retrospective observational study
SM Kim, HS Lee, NY Hwang, K Kim… - Drug Design …, 2021 - Taylor & Francis
Background To date, outcome data with a large sample size and data regarding the clinical
outcomes of pharmacokinetic-guided (PK) dosing of vancomycin are limited. Aim We …
outcomes of pharmacokinetic-guided (PK) dosing of vancomycin are limited. Aim We …
[HTML][HTML] Optimizing vancomycin dosing in chronic kidney disease by deriving and implementing a web-based tool using a population pharmacokinetics analysis
SR Dorajoo, CL Winata, JHF Goh, ST Ooi… - Frontiers in …, 2019 - frontiersin.org
Background: Chronic kidney disease (CKD) patients requiring intravenous vancomycin bear
considerable risks of adverse outcomes both from the infection and vancomycin therapy …
considerable risks of adverse outcomes both from the infection and vancomycin therapy …
Comparison of Vancomycin Trough–Based and 24-Hour Area Under the Curve Over Minimum Inhibitory Concentration (AUC/MIC)–Based Therapeutic Drug …
WXS Lim, XFV Seah, KC Thoon… - The Journal of Pediatric …, 2023 - meridian.allenpress.com
OBJECTIVES Vancomycin 24-hour area under the curve over minimum inhibitory
concentration (AUC/MIC) monitoring has been recommended over trough-based monitoring …
concentration (AUC/MIC) monitoring has been recommended over trough-based monitoring …
[HTML][HTML] Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against gram-positive pathogens?
FR Pires, SI Paula, AF Delgado… - Revista Brasileira de …, 2020 - SciELO Brasil
Objetivo: Investigar a efetividade da vancomicina contra Gram-positivos com concentração
inibitória mínima de 1mg/L em pacientes pediátricos com base na razão entre área sob a …
inibitória mínima de 1mg/L em pacientes pediátricos com base na razão entre área sob a …
A multicentric, randomised, controlled clinical trial to study the impact of bedside model-informed precision dosing of vancomycin in critically ill children–BENEFICIAL …
PA De Cock, R Colman, A Amza, P De Paepe… - 2024 - researchsquare.com
Background Vancomycin is a commonly prescribed antibiotic to treat serious Gram-positive
infections in children. The efficacy of vancomycin is known to be directly related to the …
infections in children. The efficacy of vancomycin is known to be directly related to the …
[PDF][PDF] Comparison between conventional dosing versus personalized pharmacokinetic dosing of vancomycin: a pilot study from a Malaysian private hospital
TL Yong, CP Chong - Int J Res Pharm Sci, 2021 - pdfs.semanticscholar.org
Vancomycin is the key therapeutic option for the treatment of highly resistant gram positive
infections caused by methicillin resistant Staphylococcus aureus (MRSA) and methicillin …
infections caused by methicillin resistant Staphylococcus aureus (MRSA) and methicillin …
[PDF][PDF] TRIỂN KHAI HIỆU CHỈNH LIỀU VANCOMYCIN THÔNG QUA GIÁM SÁT NỒNG ĐỘ THUỐC TRONG MÁU THEO ƯỚC ĐOÁN BAYESIAN TẠI KHOA NHI BỆNH …
TTHỊ VÂN ANH - canhgiacduoc.org.vn
Tôi xin gửi lời cảm ơn chân thành và sâu sắc đến PGS. TS. Nguyễn Hoàng Anh, Giám đốc
Trung tâm DI & ADR Quốc Gia, Giảng viên bộ môn Dược lực, Phó Trưởng khoa Dược–Bệnh …
Trung tâm DI & ADR Quốc Gia, Giảng viên bộ môn Dược lực, Phó Trưởng khoa Dược–Bệnh …
[HTML][HTML] A vancomicina administrada na dose empírica garante a cobertura de pacientes pediátricos contra patógenos Gram-positivos?
FR Pires, SI Paula, AF Delgado… - Revista Brasileira de …, 2020 - SciELO Brasil
Objetivo: Investigar a efetividade da vancomicina contra Gram-positivos com concentração
inibitória mínima de 1mg/L em pacientes pediátricos com base na razão entre área sob a …
inibitória mínima de 1mg/L em pacientes pediátricos com base na razão entre área sob a …